91Å·ÃÀ¼¤Çé

TG Therapeutics: Q2 Earnings Snapshot

MORRISVILLE, N.C. (AP) — MORRISVILLE, N.C. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported second-quarter net income of $7.8 million.

The Morrisville, North Carolina-based company said it had net income of 5 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 41 cents per share.

The biopharmaceutical company posted revenue of $240.3 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $230.9 million.

TG Therapeutics expects full-year revenue of $950 million.

_____

This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/TGTX

Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal 91Å·ÃÀ¼¤Çé Network Logo
Log in to your 91Å·ÃÀ¼¤Çé account for notifications and alerts customized for you.